Skip to content

Clinical trials

Completed Alzheimer Disease trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Austria Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20062
20074
20083
20091
20102
20111
20131
20141
20152
20163
20171
20181
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Affiris AG7
GlaxoSmithKline4
Axon Neuroscience SE3
Boehringer Ingelheim3
AstraZeneca1
Avraham Pharmaceuticals Ltd1
GE Healthcare1
JANSSEN Alzheimer Immunotherapy Research & Development, LLC1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Medical University of Graz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease28
Dementia5
Cognitive Dysfunction3
Frontotemporal Dementia2
Memory Disorders2
Pick Disease of the Brain2
Amyloidosis1
Anxiety Disorders1
Brain Diseases1
Central Nervous System Diseases1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.